Acquiring Company
Labcorp
Acquired Company
Personal Genome Diagnostics Inc.
BurlingtonMarylandBiotechnologyHealth CareMedicalHealth DiagnosticsBiotechnologyDescription
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products. The addition of PGDx and its technology complements and accelerates Labcorp’s existing liquid biopsy capabilities and expands Labcorp’s leading oncology portfolio of next-generation sequencing (NGS)-based genomic profiling capabilities, positioning Labcorp at the forefront of driving better patient outcomes in oncology.
Quick answer
Labcorp is acquiring Personal Genome Diagnostics Inc., announced February 21, 2022. Labcorp is based in Burlington, North Carolina, United States.
- Who acquired Personal Genome Diagnostics Inc?
- Labcorp agreed to acquire Personal Genome Diagnostics Inc. on February 21, 2022.
- How much did Labcorp pay for Personal Genome Diagnostics Inc?
- The deal value was not disclosed.
- What does Labcorp do?
- Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
- Where are Labcorp and Personal Genome Diagnostics Inc. based?
- Labcorp is based in Burlington, North Carolina, United States. Personal Genome Diagnostics Inc. is based in Maryland, United States.
- Who are the decision-makers at Labcorp?
- Fundz holds 1 contact at Labcorp. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Health Diagnostics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Element Biosciences Closes Acquisition Of Loop Genomics (February 8, 2022)
- Intellia Therapeutics Announces Acquisition Of Rewrite Therapeutics (February 3, 2022)
- Nichols Portland, Inc., A Portfolio Company Of Altus Capital Partners, Acquires Alpha Precision Group Llc (January 10, 2022)
- Valo Health Acquires Tara Biosystems Creating First Of Its Kind Vertically Integrated Cardiovascular Platform (April 5, 2022)
- Im Cannabis Closes Previously Announced Acquisition Of Oranim Pharm, Jerusalem'S Leading Medical Cannabis Pharmacy (March 30, 2022)
- Incannex To Acquire Apirx Pharmaceuticals Usa, Llc (March 24, 2022)
Who to call at Labcorp, and when
When Labcorp changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Labcorp raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Labcorp, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Labcorp. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Labcorp makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Personal Genome Diagnostics Inc.?
Personal Genome Diagnostics Inc. was acquired by Labcorp, based in Burlington. The deal was reported on February 21, 2022. Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Labcorp is publicly traded (LH) and operates in Biotechnology.
When did Labcorp acquire Personal Genome Diagnostics Inc.?
Labcorp's acquisition of Personal Genome Diagnostics Inc. was reported on February 21, 2022. Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Personal Genome Diagnostics Inc. do?
Personal Genome Diagnostics Inc. develops patient-specific analysis of the cancer genome by using advanced tools and technologies. It is privately held, operating in Biotechnology, and is based in Maryland.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.